Radiology Doctors in Seneca, SC Accepting Medicare

3 Radiology doctors found. Showing 1 - 3

Mr. James Hardy, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1059 By Pass 123, Seneca, SC 29678 Phone: 864-885-0551    Fax: 864-885-1822

Mr. Osman A. Hicklin Iii, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1059 By Pass 123, Seneca, SC 29678 Phone: 864-885-0551    Fax: 864-885-1822

Mr. Thomas M. Doud, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1059 By Pass 123, Seneca, SC 29678 Phone: 864-885-0551    Fax: 864-885-1822

News Archive

Structural alterations in breast stromal and epithelial DNA

Researchers have uncovered a pattern of DNA damage in connective tissues in the human breast that could shed light on the early stages of breast cancer.

Researchers identify 25 human proteins that may be crucial for HIV-1 infection and survival

Studying HIV-1, the most common and infectious HIV subtype, Johns Hopkins scientists have identified 25 human proteins "stolen" by the virus that may be critical to its ability to infect new cells. HIV-1 viruses capture many human proteins from the cells they infect but the researchers believe these 25 proteins may be particularly important because they are found in HIV-1 viruses coming from two very different types of infected cells.

NPR blog examines debate over option B+ HIV prevention strategy

NPR's "Shots" blog examines the debate over Option B+, a strategy to prevent mother-to-child HIV transmission that "aims to put every pregnant woman with HIV on triple-drug treatment and keep her on it for the rest of her life - even if the virus has not yet damaged her immune system to the point where she needs medications to preserve her own health."

Scientists identify molecular partnership that may help explain how pancreatic cancer spreads

Scientists at the Johns Hopkins Kimmel Cancer Center have identified a molecular partnership in pancreatic cancer cells that might help to explain how the disease spreads — metastasizes — in some cases. Their findings reveal urgently needed new targets to treat pancreatic cancer, which strikes nearly 50,000 people in the U.S. each year and has only a 5 percent survival rate five years after diagnosis.

CITN selects Cytheris' CYT107 for initial clinical trials at network institutions

Cytheris SA and the Cancer Immunotherapy Trials Network, a new initiative in immunotherapy funded by the National Cancer Institute with its Central Operations and Statistical Center headquartered at Fred Hutchinson Cancer Research Center, Seattle, Washington, today announced the selection of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, as one of the first immunotherapeutic agents proposed for initial clinical trials at network institutions.

Read more Medical News

› Verified 5 days ago